JP6178843B2 - 透過性グリコシダーゼインヒビターおよびその用途 - Google Patents
透過性グリコシダーゼインヒビターおよびその用途 Download PDFInfo
- Publication number
- JP6178843B2 JP6178843B2 JP2015511546A JP2015511546A JP6178843B2 JP 6178843 B2 JP6178843 B2 JP 6178843B2 JP 2015511546 A JP2015511546 A JP 2015511546A JP 2015511546 A JP2015511546 A JP 2015511546A JP 6178843 B2 JP6178843 B2 JP 6178843B2
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- tetrahydro
- pyrano
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC(O[C@@]([C@@]1N=C(N(C)C)S[C@]1O[C@@]1C*)[C@@]1OC(C)=O)=O Chemical compound CC(O[C@@]([C@@]1N=C(N(C)C)S[C@]1O[C@@]1C*)[C@@]1OC(C)=O)=O 0.000 description 7
- PSKWHGLUXFFPNH-VFZPANTDSA-N CC(C)(C)OC(N(C)C(S[C@H]1O[C@H]([C@H](C(F)(F)F)OC)[C@H]2O)=N[C@@H]1[C@H]2O)=O Chemical compound CC(C)(C)OC(N(C)C(S[C@H]1O[C@H]([C@H](C(F)(F)F)OC)[C@H]2O)=N[C@@H]1[C@H]2O)=O PSKWHGLUXFFPNH-VFZPANTDSA-N 0.000 description 1
- HUNQQCIVZAHDGF-HWTGPMJESA-N CN(C)C(S[C@H]1O[C@H](C(C(F)(F)F)Oc2ccccc2)[C@H]2OCc3ccccc3)=N[C@@H]1[C@H]2OCc1ccccc1 Chemical compound CN(C)C(S[C@H]1O[C@H](C(C(F)(F)F)Oc2ccccc2)[C@H]2OCc3ccccc3)=N[C@@H]1[C@H]2OCc1ccccc1 HUNQQCIVZAHDGF-HWTGPMJESA-N 0.000 description 1
- XZLBZKHLKVSWGY-BSKUUZOQSA-N CNC(S[C@H]1O[C@H]([C@@H](C(F)(F)F)Oc2ccccc2)[C@H]2O)=N[C@@H]1[C@H]2O Chemical compound CNC(S[C@H]1O[C@H]([C@@H](C(F)(F)F)Oc2ccccc2)[C@H]2O)=N[C@@H]1[C@H]2O XZLBZKHLKVSWGY-BSKUUZOQSA-N 0.000 description 1
- XZLBZKHLKVSWGY-PQCBQTOFSA-N CNC(S[C@H]1O[C@H]([C@H](C(F)(F)F)Oc2ccccc2)[C@H]2O)=N[C@@H]1[C@H]2O Chemical compound CNC(S[C@H]1O[C@H]([C@H](C(F)(F)F)Oc2ccccc2)[C@H]2O)=N[C@@H]1[C@H]2O XZLBZKHLKVSWGY-PQCBQTOFSA-N 0.000 description 1
- DNCMJHKNHROSET-NTXXKDEISA-N C[C@H]([C@H]1N=C(NC)S[C@H]1O[C@@H]1[C@H](C(F)(F)F)OC)[C@@H]1O Chemical compound C[C@H]([C@H]1N=C(NC)S[C@H]1O[C@@H]1[C@H](C(F)(F)F)OC)[C@@H]1O DNCMJHKNHROSET-NTXXKDEISA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2012/075185 | 2012-05-08 | ||
| PCT/CN2012/075185 WO2013166654A1 (en) | 2012-05-08 | 2012-05-08 | Permeable glycosidase inhibitors and uses thereof |
| US201261655641P | 2012-06-05 | 2012-06-05 | |
| US61/655,641 | 2012-06-05 | ||
| PCT/US2013/039377 WO2013169576A1 (en) | 2012-05-08 | 2013-05-03 | Permeable glycosidase inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015516420A JP2015516420A (ja) | 2015-06-11 |
| JP2015516420A5 JP2015516420A5 (enExample) | 2016-06-23 |
| JP6178843B2 true JP6178843B2 (ja) | 2017-08-09 |
Family
ID=49551168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511546A Expired - Fee Related JP6178843B2 (ja) | 2012-05-08 | 2013-05-03 | 透過性グリコシダーゼインヒビターおよびその用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9611275B2 (enExample) |
| EP (1) | EP2847199B1 (enExample) |
| JP (1) | JP6178843B2 (enExample) |
| KR (1) | KR102108586B1 (enExample) |
| CN (1) | CN104395323B (enExample) |
| AU (1) | AU2013259892B2 (enExample) |
| BR (1) | BR112014027724B1 (enExample) |
| CA (1) | CA2871920C (enExample) |
| RU (1) | RU2707292C2 (enExample) |
| WO (1) | WO2013169576A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9079868B2 (en) | 2008-08-01 | 2015-07-14 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| US9120781B2 (en) | 2010-05-11 | 2015-09-01 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| EP2638052B1 (en) | 2010-11-08 | 2017-03-22 | Alectos Therapeutics, Inc. | Selective glycosidase inhibitors and uses thereof |
| PL2655388T3 (pl) | 2010-12-23 | 2016-12-30 | Selektywne inhibitory glikozydazy i ich zastosowania | |
| WO2012126091A1 (en) | 2011-03-24 | 2012-09-27 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| US9718854B2 (en) | 2011-03-31 | 2017-08-01 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| EP2726492B1 (en) | 2011-06-27 | 2017-11-01 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| US9199949B2 (en) | 2011-06-27 | 2015-12-01 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| US9409924B2 (en) | 2011-06-27 | 2016-08-09 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2014032185A1 (en) | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| WO2014032188A1 (en) | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| RU2672873C2 (ru) | 2012-10-31 | 2018-11-20 | Алектос Терапьютикс Инк. | Ингибиторы гликозидаз и их применения |
| WO2014100934A1 (en) | 2012-12-24 | 2014-07-03 | Merck Sharp & Dohme Corp. | Glycosidase inhibitors and uses thereof |
| DK3008168T3 (da) | 2013-06-11 | 2020-05-04 | Harvard College | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf |
| CA2966620A1 (en) | 2014-11-05 | 2016-05-12 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
| CA2975583A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
| KR20220108216A (ko) | 2016-05-18 | 2022-08-02 | 보이저 테라퓨틱스, 인크. | 헌팅톤 질환을 치료하기 위한 조성물 및 방법 |
| KR20240056729A (ko) | 2016-05-18 | 2024-04-30 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| SG11201909868YA (en) | 2017-05-05 | 2019-11-28 | Voyager Therapeutics Inc | Compositions and methods of treating huntington's disease |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| MX2020012077A (es) | 2018-05-15 | 2021-03-09 | Voyager Therapeutics Inc | Composiciones y metodos para el tratamiento de la enfermedad de parkinson. |
| CN110407674A (zh) * | 2018-08-14 | 2019-11-05 | 重庆市化工研究院 | 4-烯丙氧基苯甲醇、合成方法及应用 |
| CN116916916A (zh) * | 2020-09-25 | 2023-10-20 | 塞维利亚大学 | 糖苷酶抑制剂及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1441749A1 (ru) * | 1987-03-16 | 1996-01-10 | Институт Тонкой Органической Химии Им.А.Л.Мнджояна | 2-АМИНО-5,5-ДИМЕТИЛ-4,5-ДИГИДРО-7Н-ПИРАНО [4,3-d] ТИАЗОЛ, ОБЛАДАЮЩИЙ ТРАНКВИЛИЗИРУЮЩЕЙ АКТИВНОСТЬЮ |
| EP1734821A4 (en) | 2004-04-14 | 2011-07-06 | Uab Research Foundation | ACTIVATORS OF HEXOSAMIN BINOSYNTHESIS AS AN INHIBITORS FOR INDUCED DAMAGE CAUSED BY ISCHEMIC SHOCK OR HEMORRHAGIC SHOCK |
| AU2006220187B2 (en) * | 2005-03-01 | 2012-11-08 | Simon Fraser University | Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| EP2057171A4 (en) * | 2006-08-31 | 2010-04-21 | Univ Fraser Simon | SELECTIVE GLYCOSIDASE INHIBITORS AND APPLICATIONS THEREOF |
| CN107253970A (zh) * | 2006-08-31 | 2017-10-17 | 西蒙·弗雷瑟大学 | 选择性糖苷酶抑制剂及其用途 |
| US9079868B2 (en) | 2008-08-01 | 2015-07-14 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| WO2010012106A1 (en) | 2008-08-01 | 2010-02-04 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| US20110301217A1 (en) | 2008-09-16 | 2011-12-08 | David Jaro Vocadlo | Selective Glycosidase Inhibitors and Uses Thereof |
| US9120781B2 (en) * | 2010-05-11 | 2015-09-01 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| WO2012061972A1 (en) * | 2010-11-08 | 2012-05-18 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| TW201249848A (en) * | 2010-11-08 | 2012-12-16 | Merck Sharp & Dohme | Selective glycosidase inhibitors and uses thereof |
| WO2012159262A1 (en) * | 2011-05-24 | 2012-11-29 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2013025452A1 (en) * | 2011-08-18 | 2013-02-21 | Merck Sharp & Dohme Corp. | Selective glycosidase inhibitors and uses thereof |
-
2013
- 2013-05-03 RU RU2014149183A patent/RU2707292C2/ru active
- 2013-05-03 CA CA2871920A patent/CA2871920C/en active Active
- 2013-05-03 CN CN201380023214.4A patent/CN104395323B/zh not_active Expired - Fee Related
- 2013-05-03 BR BR112014027724-9A patent/BR112014027724B1/pt not_active IP Right Cessation
- 2013-05-03 EP EP13787989.6A patent/EP2847199B1/en active Active
- 2013-05-03 JP JP2015511546A patent/JP6178843B2/ja not_active Expired - Fee Related
- 2013-05-03 WO PCT/US2013/039377 patent/WO2013169576A1/en not_active Ceased
- 2013-05-03 AU AU2013259892A patent/AU2013259892B2/en not_active Ceased
- 2013-05-03 US US14/399,146 patent/US9611275B2/en not_active Expired - Fee Related
- 2013-05-03 KR KR1020147031131A patent/KR102108586B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2871920C (en) | 2021-03-09 |
| CN104395323A (zh) | 2015-03-04 |
| CA2871920A1 (en) | 2013-11-14 |
| RU2707292C2 (ru) | 2019-11-26 |
| EP2847199B1 (en) | 2017-10-25 |
| KR102108586B1 (ko) | 2020-05-07 |
| EP2847199A1 (en) | 2015-03-18 |
| JP2015516420A (ja) | 2015-06-11 |
| US9611275B2 (en) | 2017-04-04 |
| RU2014149183A (ru) | 2016-06-27 |
| AU2013259892B2 (en) | 2017-09-14 |
| EP2847199A4 (en) | 2015-11-11 |
| CN104395323B (zh) | 2017-08-01 |
| AU2013259892A1 (en) | 2014-10-30 |
| US20150152127A1 (en) | 2015-06-04 |
| BR112014027724A2 (enExample) | 2017-08-22 |
| BR112014027724B1 (pt) | 2022-05-03 |
| KR20150006841A (ko) | 2015-01-19 |
| WO2013169576A1 (en) | 2013-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6178843B2 (ja) | 透過性グリコシダーゼインヒビターおよびその用途 | |
| JP6147737B2 (ja) | 選択的グリコシダーゼ阻害剤およびその使用 | |
| JP5771237B2 (ja) | 選択的グリコシダーゼ阻害剤およびその使用 | |
| EP2637503B1 (en) | Selective glycosidase inhibitors and uses thereof | |
| RU2672873C2 (ru) | Ингибиторы гликозидаз и их применения | |
| EP2744338B1 (en) | Selective glycosidase inhibitors and uses thereof | |
| WO2012061972A1 (en) | Selective glycosidase inhibitors and uses thereof | |
| HUE030624T2 (en) | Selective glycosidase inhibitors and their use | |
| WO2012126091A1 (en) | Selective glycosidase inhibitors and uses thereof | |
| US8901087B2 (en) | Selective glycosidase inhibitors and uses thereof | |
| WO2013166654A1 (en) | Permeable glycosidase inhibitors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160428 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160428 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161208 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161213 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170307 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170609 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170620 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170714 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6178843 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |